Quest Diagnostics announced a quarterly cash dividend of $0.86 per share, payable on January 27, 2027, to shareholders of record as of January 12, 2027. This dividend reflects the company's ongoing commitment to returning value to its shareholders. Quest Diagnostics is a leading diagnostic information services provider serving a large portion of U.S. physicians and hospitals, emphasizing its role in healthcare innovation and management.
Quest Diagnostics shares trade at USD 258.46 on Pluang as of Nov 11, 2026, 04:02 WIB, slightly down 0.47% for the day. The stock's dividend yield stands at 1.32%, aligning with the recent dividend announcement. Investors on Pluang hold the stock for an average of 57 days, showing steady interest in this healthcare sector leader.
Quest Diagnostics announced that Sam Samad, their Executive Vice President and CFO, will participate in a fireside chat at the 9th Annual Evercore Healthcare Conference on December 1, 2026. The event will be webcast live and available for replay unti...
Quest Diagnostics announced that Sam Samad, their Executive Vice President and CFO, will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on November 17, 2026. The session will be webcast live and available on th...
